Chris Davis Viatris Inc Transaction History
Davis Selected Advisers
- $16.9 Billion
- Q1 2025
A detailed history of Chris Davis (Davis Selected Advisers) transactions in Viatris Inc stock. As of the latest transaction made, Davis Selected Advisers holds 64,948,236 shares of VTRS stock, worth $549 Million. This represents 3.35% of its overall portfolio holdings.
Number of Shares
64,948,236
Previous 62,573,562
3.8%
Holding current value
$549 Million
Previous $779 Million
27.39%
% of portfolio
3.35%
Previous 4.62%
Shares
18 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
953MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.22 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$784 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$630 Million0.08% of portfolio
-
State Street Corp Boston, MA61.5MShares$520 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA31.2MShares$264 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $10.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...